Mifepristone 200 mg is a synthetic steroid compound widely recognized for its role as an antiprogestogen, meaning it blocks the action of the hormone progesterone. By interfering with progesterone activity, it alters the uterine environment, making it unsuitable for the continuation of pregnancy. This property has made Mifepristone an important option in medical practice, particularly in combination with other agents, for the management of early pregnancy termination under regulated medical supervision. Beyond this, it has also been studied and applied in certain gynecological conditions where controlling progesterone levels is beneficial, such as in the treatment of uterine fibroids or endometriosis. Its mechanism of action involves binding to progesterone receptors, thereby preventing the hormone from exerting its effects on the endometrium and other reproductive tissues.